You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
1 June 2026 - Biotechnology company Anixa Biosciences Inc (NASDAQ: ANIX) reported on Monday that it has received a Notice of Allowance from the Canadian Intellectual Property Office for a patent covering key aspects of its ovarian cancer vaccine tech...
1 June 2026 - Clinical development partner hVIVO plc (AIM: HVO) announced on Monday that it has signed a consultancy agreement with Decoy Therapeutics to support the development of its respiratory antiviral portfolio, positioning the programmes for p...
1 June 2026 - Clinical-stage biotechnology companies Rallybio Corporation (Nasdaq:RLYB) and Avenzo Therapeutics Inc announced on Monday that they have entered into a definitive merger agreement under which Rallybio will acquire Avenzo, with the combi...
1 June 2026 - Particle accelerator technology company Ion Beam Applications S.A. (IBA) (Euronext Brussels:IBAB) announced on Monday the launch of Cyclone iKure, a dedicated cyclotron designed for routine production of Astatine-211 (At-211) to support...
1 June 2026 - Biotechnology companie Circio Holding ASA (OSE:CRNA) and GenAssist Ltd announced on Monday that they have entered into a research collaboration to develop circVec-enhanced AAV vectors for in vivo cell therapy and targeted systemic gene ...
1 June 2026 - Biopharmaceutical company Avacta Group PLC (AIM: AVCT) announced on Monday that it has presented updated clinical data from its Phase 1a/1b trial of AVA6000, its pre|CISION-enabled form of doxorubicin, highlighting encouraging early eff...
1 June 2026 - Chinese biopharmaceutical company Dizal (SSE:688192) announced on Saturday the presentation of two studies in non-small cell lung cancer (NSCLC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.One study evaluated...